Study # |
Test Article |
Formulation |
Route |
Dose (mg/kg) |
Dose vol. (mL/kg) |
Study
Nature |
Time (hr) |
Study 1a |
[125I]Peptide A |
IR |
IV |
0.5 |
1 |
PK |
0, 0.083,
0.25, 0.5,
1, 2, 3, 4,
6, 24, 72
and 240 |
Study 2 |
Peptide A |
IR |
SC |
2 |
0.4 |
PK |
0.5, 1, 2,
3, 4, 6, 8,
12, 24, 30
and 48 |
Study 3 |
Peptide A |
CR |
SC |
2 |
0.4 |
PK |
0, 0.5, 1,
2, 3, 4, 6,
24, 72 and
240 |
Study 4 |
[125I]Peptide A |
IR |
SC |
2 |
0.4 |
Tissue
Distribution |
0, 0.5, 1,
3 and 7 |
Study 5 |
[125I]Peptide A |
CR |
SC |
2 |
0.4 |
Tissue
Distribution |
0, 1, 6,
24, 72 and |
Study 6 |
[125I]Peptide A |
IR |
SC |
2 |
0.4 |
Metabolite
Profile |
1, 2 and 3 |
Study 7 |
[125I]Peptide A |
CR |
SC |
2 |
0.4 |
Metabolite
Profile |
1, 2 and 3 |
aN=5 for study 1, N=3 in study 2-7.
Abbreviations: IR-instant release, CR-controlled release. |